Table 1 Patients characteristics and Rap2a expression.
Variables | Rap2a staining | |||
|---|---|---|---|---|
Negative (%) | Positive (%) | Total | P* | |
All cases | 40 (21.2) | 149 (78.8) | 189 | 0.000 |
Age | ||||
≤57 years | 17 (23.6) | 55 (76.4) | 72 | 0.518 |
>57 years | 23 (19.7) | 94 (80.3) | 117 | |
Gender | ||||
Male | 28 (23.1) | 93 (76.9) | 121 | 0.375 |
Female | 12 (17.6) | 56 (82.4) | 68 | |
Tumor size | ||||
≤7 cm | 29 (22.5) | 100 (77.5) | 129 | 0.516 |
>7 cm | 11 (18.3) | 49 (81.7) | 60 | |
pT status | ||||
pT1 | 25 (23.1) | 83 (76.9) | 108 | 0.854 |
pT2 | 7 (20.0) | 28 (80.0) | 35 | |
pT3 | 9 (19.6) | 37 (80.4) | 46 | |
pN status | ||||
pN0 | 35 (21.9) | 125 (78.1) | 160 | 0.319 |
pN1 | 5 (23.8) | 16 (76.2) | 21 | |
pN2-pN3 | 0(0.0) | 8 (100.0) | 8 | |
TNM stage | ||||
I | 22 (22.4) | 76 (77.6) | 98 | 0.800 |
II | 6 (20.7) | 23 (79.3) | 29 | |
III | 6 (21.4) | 22 (78.6) | 28 | |
IV | 6 (17.6) | 28 (82.4) | 34 | |